In addition, the potential molecular mechanism of TAF7 affecting ccRCC progression was detected by western blotting, as indicated by the results, the knockdown of TAF7 inhibited the levels of S-phase related proteins CDK2 and cyclin A2, thereby affecting cell cycle progression. Here, TAF7 is linked to nonpapillary renal cell carcinoma.